“One of the biggest challenges to medicine is the incorporation of information technology in our practices.” – Samuel Wilson.
Century Pharmaceuticals Ltd. was established in 1982 and has a track record of healthy growth since inception. It has a rich experience of over three decades in the pharmaceutical industry with impeccable record of quality products in the market. They are having an in-house R&D center for making cost effective API drugs. They have received many awards and certified at the national and International level. Their certification and award list includes: ISO 9001 for QMS, ISO 14001 for EMS, OHSAS 18001 for OHSMS, ‘A1’ SME company by Dun and Bradstreet, Gold Medal for excellence in Business Practices, Excellence award for Exports, Excellence for Innovation, Quality, Productivity by IES, India, Gold Award from Lockheed Martin in Biotechnology, FGI award for excellence “outstanding MSME”, Leaders of tomorrow by ET NOW and Quality Mark Trust Award. India Inc. has conferred them the certificate of excellence for innovation in India Innovative 100 Magazine.
They have made significant investment in latest technology to implement quality systems and manufacturing systems to ensure data integrity and complete automation of shop floor and quality systems. Adoption of digital initiatives has improved their efficiency and the quality of products. This is enhancing productivity significantly and thus addressing most of the issues. Technology is also helping them to get closer to mobile phones and social media.
The Indian pharmaceutical industry, the most respected amongst the emerging nations, is one of the most sought after sectors from a global collaboration point of view. The sector is expected to grow to $45 billion by 2020.Exports continue to make a significant contribution to the industry growth story. Critical and developed markets are driving growth in the generics segment. Apart from the developed markets, Indian pharma companies have established a strong presence in other fast growing semi-regulated markets like Russia, South Africa and Latin America. Century Pharma is in very strong position due to export oriented unit and supplying to prestigious customers in regulated as well as non-regulated market.
CPL Biotech Research division drug discovery and development was initiated in 2007 and they are committed to discover and develop biotechnology drugs. Century recognizes the role of Biotechnology as the future of the pharmaceutical industry in enhancing the specificity and effectiveness of drugs, improving lifestyle quality and working on unmet needs of the industry. Their R&D has developed Recombinant fusion protein for the Treatment of asthma and Mastocytosis. Currently they are also involved in Stem cell research to provide a solution for the terminal cases where there is no treatment available. The company is providing tailor made products specifically required by different pharmaceutical companies and are always ready to resolve any quality query faced by their prestigious clients.
Additionally, they are having Biotechnology unit working on an innovative novel molecule for the treatment and cure for Asthma drugs. They have also done a good amount of work on use of Stem cells in the treatment of various diseases, focusing on specifically on quality products, consistent quality and delivery of services in time. They always try to understand specific requirements from their customers and continuous feedback helps them to meet their quality requirements.
A futuristic customer centric approach
Requirement of the clients is quality products with higher potency products and minimum level of known / unknown impurities. They have focused to reduce impurity level at lowest level with the experience and with capable team of R&D scientists. Their target area is National and International market including some new countries from Africa, Europe and US. They are focused to add value to the product and also they want to add few Biotechnology products through fermentation and modified fermentation product. They are regularly supplying the products to : Pfizer, IPCA, Jubilant, Aristo, TEVA, Cipla, Macleods, Zydus, Cadila, Glenmark, Wockhardt, Flamingo, Lupin, Intas, Hetero drugs, Abbott etc. Their customers are completely satisfied with the services and they get repeat orders. They are capable of meeting customer’s specific requirements and serving many customers for more than 30 years with their consistent quality products. They always keep records of audits, feedback from customers and work continuously to improve their existing systems.
Talking about satisfied customers, Century had a customer whose quality specifications were very weird causing them a lot of processing costs making the product expensive. Century worked hard with the customer and encouraged them to try Century’s revised specifications of the same product which was cost effective to make and yet maintained high level of quality in customer’s finished product. Century’s focus area includes better employment opportunities and to drive the Indian economy to the next level. Focusing on developing new products to meet the needs of the society, Century reveals that dealing with raising customer expectations and technology transfers is quite challenging but yet achievable and they have spared no effort to make this successful.
Meet the Master
Janak Sheth, Managing Director: Janak is a Chemical Engineer and an IIT Delhi Graduate. He is an outstanding business leader with a broad and deep understanding of the International Market. Throughout his career, he has progressed through a number of management and executive leadership positions He look forward to leveraging his extensive knowledge and leadership garnered from his experience. He has been awarded as 9dot9 media listed and rated “Janak K Sheth” from Indian Top 30 CEO on Innovation CEO of the year 2014.
Benchmark Electronics will develop Qualcomm’s biometric patches to monitor vital signs and track patients